High-density lipoproteins (HDL) have several antiatherogenic actions, inclu
ding the ability to sequester cellular cholesterol, to protect low-density
lipoproteins from oxidation and to inhibit platelet aggregation. An early e
vent in atherogenesis is the adhesion and recruitment of blood monocytes, a
process mediated by cell adhesion molecules (CAMs), including vascular cel
l adhesion molecule-1 (VCAM-1) which is rapidly synthesized by endothelial
cells in response to cytokines. It has been reported that HDL limits CAM ex
pression in cultured human umbilical vein endothelial cells (HUVECs), imply
ing that HDL also protects at an early stage in lesion development. Here, w
e have studied HDL suppression of CAM induction in human coronary artery en
dothelial cells (HCAECs), a model directly relevant to blood vessels suscep
tible to atherosclerosis. Arterial endothelial cells were preincubated with
increasing amounts of total HDL, or different subfractions, and then activ
ated with the inflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha
). Flow cytometric analysis failed to detect any downregulation of VCAM-1 o
r E-selectin expression by HDL in this model of vascular endothelium. Moreo
ver, we were unable to confirm that HDL could suppress CAM induction in wel
l-characterized, low-passage HUVECs, even though positive controls, 17 beta
-estradiol or a nitric oxide donor, did cause downregulation and factors s
uch as variability in donors and HDL preparation, or culture conditions, we
re excluded. We tentatively conclude that, as isolated HDL. did not downreg
ulate CAM expression in cultured HCAECs or HUVECs, attenuation of CAM induc
tion in arterial endothelium is unlikely to contribute to HDL antiatherogen
ic actions in vivo. (C) 2001 Elsevier Science Ireland Ltd. All rights reser
ved.